Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fast skeletal muscle troponin-tropomyosin complex is a critical regulatory assembly located on the thin filaments of fast-twitch (Type II) muscle fibers. It consists of three troponin subunits—troponin C (TnC), troponin I (TnI), and troponin T (TnT)—alongside tropomyosin (UniProt: P02585). In the resting state, the complex inhibits the interaction between actin and myosin; upon calcium binding to TnC, a conformational change occurs that shifts tropomyosin, exposing myosin-binding sites on actin and initiating muscle contraction (PubMed: 21975163). This complex serves as a therapeutic target for conditions characterized by muscle weakness or fatigue, such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) (PubMed: 33403334). Pharmacological agents known as fast skeletal muscle troponin activators (FSTAs), such as tirasemtiv and reldesemtiv, bind to the complex to increase its sensitivity to calcium. By slowing the dissociation of calcium from TnC, these drugs enhance muscle force production during submaximal nerve stimulation, potentially improving physical function and respiratory capacity in patients with neuromuscular disorders (Cytokinetics, 2023). Clinical development has focused on leveraging this mechanism to provide functional benefits to patients with compromised motor neuron activity.
Fast skeletal muscle troponin activation; the drugs bind to the troponin complex and increase its sensitivity to calcium by slowing the rate of calcium dissociation from troponin C, thereby enhancing muscle force production at submaximal nerve stimulation (PubMed: 21975163).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fast skeletal muscle troponin-tropomyosin complex (fsTn-Tm).